Archean Chemical Industries Limited reported its Q4 and full-year financial performance for FY ’26. Despite facing headwinds from logistics challenges and the U.S.-Iran conflict, the company remains focused on its core salt and bromine businesses. The company achieved INR 1,088.8 crore in revenue for the full year and is advancing strategic growth in semiconductors, derivatives, and oilfield chemicals, backed by strong customer relationships and a commitment to operational excellence.
Financial Performance Overview
For the quarter ended March 31, 2026, Archean Chemical Industries Limited reported a total income of INR 304.7 crore, reflecting a 9% year-on-year decrease. The company’s EBITDA for the quarter stood at INR 66.4 crore, with an EBITDA margin of 21.79%. Profit after tax for the quarter was INR 29.8 crore. On a full-year basis, the company recorded revenue of INR 1,088.8 crore, with profit after tax reaching INR 154.3 crore.
Segment and Operational Highlights
Industrial salt volumes for the quarter reached 1.1 million tons, while the company achieved 4.2 million tons for the full year, a 22% increase over the previous year. Bromine volumes were reported at 3,731 metric tons for the quarter, up 4% year-on-year. The company has successfully renegotiated a majority of its long-term bromine contracts to reflect current market dynamics, aiming to improve future realizations.
Strategic Growth Initiatives
The company continues to diversify its portfolio through key strategic projects:
- Semiconductors: The subsidiary, SiCSem, has signed a fiscal support agreement with the Government of India for its semiconductor project in Odisha, enabling the acceleration of project execution.
- Bromine Derivatives: Housed under Acume Chemicals Private Limited, this segment saw full-year revenue grow by nearly 300%. The company is currently optimizing processes and launching new products to drive margins.
- Oilfield Operations: Through Idealis Mudchemie, the company is commissioning plants and undergoing customer trials, with expectations for a ramp-up in the second half of the fiscal year as oil and gas activity normalizes.
Future Outlook
Management highlighted three strategic priorities: consolidating core salt and bromine businesses, scaling up derivatives and oilfield services, and investing in advanced materials. Despite short-term logistics and geopolitical headwinds, the company maintains a positive medium-term outlook for its key end-markets and remains committed to capital discipline and operational efficiency.
Source: BSE
